TIMP1 and triple-A syndrome: Short-term doxycycline treatment (2-weeks) increased TIMP-1 and reduced MMP-8, MMP-9, MMP-3, and MMP-25 expression, resulting in a decrease of inflammatory cell accumulation within diseased aorta of AAA patients (184, 185).